No drugs for prions: could new approaches alleviate therapeutic scarcity?
The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the complex nature of these diseases. Also referred to as prion diseases, TSEs are rare and...
Comment
View MoreSmart pharma is no longer a buzzword: pharma technological breakthroughs at PHARMAP 2026
In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma are disappearing and have now declined to 1% in 2025.…
Advancing single-cell transcriptomics into the mainstream of biomedical research
Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience
The new safety mandate driving AI-ready pharmacovigilance
When trillion‑member libraries meet physics: what diversity really means